共 222 条
[1]
Hoen B(2013)Infective endocarditis New Engl J Med 368 1425-1433
[2]
Duval X(2015)2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J 36 3075-3128
[3]
Habib G(2015)Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association Circulation 132 143586-4079
[4]
Lancellotti P(2009)Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis Antimicrob Agents Chemother 53 4069-62
[5]
Antunes MJ(1992)Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin Clin Infect Dis 15 58-1393
[6]
Bongiorni MG(2001)Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis Antimicrob Agents Chemother 45 1387-212
[7]
Casalta JP(2008)Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis J Chemother 20 208-136
[8]
Del Zotti F(1985)Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis Antimicrob Agents Chemother 27 135-830
[9]
Dulgheru R(1990)Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a β-lactamase-producing strain of Antimicrob Agents Chemother 34 827-57
[10]
El Khoury G(1986) with high-level resistance to gentamicin Antimicrob Agents Chemother 29 52-876